This inventor holds 8 USPTO granted patents and 2 published patent applications, plus 1 CIPO patent. Top assignees: The University of Texas System, Albert Einstein College of Medicine. Active years: 2010-2025.
Location History:
- Southlake, TX (US) (2010 - 2021)
- Dallas, TX (US) (2023 - 2024)
Company Filing History:
7 out of 5,630 
1 out of 513 
Years Active: 2010-2025
Title: The Innovative Contributions of Philipp Erich Scherer
Introduction
Philipp Erich Scherer is a notable inventor based in Southlake, TX (US). He has made significant contributions to the field of biotechnology, particularly in the development of monoclonal antibodies. With a total of 8 patents, Scherer has focused on innovations that aim to improve therapeutic outcomes for patients.
Latest Patents
Scherer's latest patents include groundbreaking work on monoclonal antibodies against endotrophin. This invention relates to methods and reagents designed to increase chemosensitivity to platinum-based chemotherapy. One of the methods involves administering an effective amount of an endotrophin-neutralizing agent to patients in need. This agent can be a monoclonal antibody or a fragment capable of binding to the C5 domain of the alpha chain of collagen VI. Additionally, his patent on leptin antibodies outlines a method for reducing leptin levels, which is crucial for treating obesity and diabetes.
Career Highlights
Throughout his career, Scherer has worked with prestigious institutions such as the University of Texas System and Albert Einstein College of Medicine. His work has been instrumental in advancing research in the medical field, particularly in the areas of obesity and cancer treatment.
Collaborations
Scherer has collaborated with notable colleagues, including Zhiqiang An and Jiyoung Park. These partnerships have further enhanced his research and contributed to the success of his innovative projects.
Conclusion
Philipp Erich Scherer exemplifies the spirit of innovation in biotechnology through his patents and collaborative efforts. His work continues to impact the medical community positively, paving the way for new treatments and therapies.